FDA Brief

Warning letters Drugs

FDA warning letter to

ALVA-AMCO Pharmacal Companies, LLC

High riskIssued Aug 9, 2023Posted Aug 15, 2023Office of Unapproved Drugs and Labeling Compliance

FDA warns ALVA-AMCO that Nauzene Kids, a children’s nausea drug, is an unapproved new drug.

What happened

FDA reviewed www.nauzenekids.com in May 2023 and found that ALVA-AMCO offers Nauzene Kids for sale in the United States. The label and website claim the product relieves nausea and upset stomachs, including from car sickness and stomach flu. FDA determined it is an unapproved new drug and referenced a July 26, 2023 warning letter to Denison Pharmaceuticals about significant current good manufacturing practice (CGMP), the quality rules for drug manufacturing, violations.

What FDA found

  1. FDA says Nauzene Kids is a new drug because its label and website claims say it treats nausea, upset stomach, car sickness, and stomach flu, and it is not generally recognized as safe and effective for those uses.

    FD&C Act sections 201(p) and 505(a), 21 U.S.C. 321(p) and 355(a)
  2. FDA says the firm introduces or delivers the product into interstate commerce without an FDA-approved drug application.

    FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)
  3. FDA says the product label and website claims show the product is intended to treat disease or affect the structure or function of the body.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)
  4. FDA says calling the product homeopathic does not exempt it from drug approval, misbranding, or adulteration requirements.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)

What FDA wants

FDA asks the company to notify it in writing within 15 working days of the specific steps taken to correct the violations and prevent recurrence, with supporting documents. If correction cannot be completed in that time, the company must state why and when it will finish.

Who should pay attention

  • retailers and websites that sell Nauzene Kids
  • parents and caregivers of young children
  • drug companies using Denison Pharmaceuticals as a contract manufacturer

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk